Arca
Skip to content
Tools
Tools

DRD4: D(4) dopamine receptor

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

G protein-coupled receptor for dopamine, a catecholamine neurotransmitter hormone that functions as the brain's 'reward chemical', driving motivation, reinforcement learning and pleasure.

  • Drugs that act on it: 2
  • Approved: 0
  • In phases 1 to 3: 2
  • Sponsors: 1

Who Is On It, and How Far Along

Every drug ChEMBL records acting on DRD4, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule

Approved0

    Phase 31

    • Sarizotan

    Phase 21

    • Clothiapine

    Phase 10

      The Landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      SarizotanPhase 3Merck KGaASmall moleculeAgonistDopamine D4 receptor agonist0—
      ClothiapinePhase 2—Small moleculeAntagonistDopamine D4 receptor antagonist0—

      Diseases Most Associated With It

      Open Targets association score, 0 to 1; all associations
      Parkinson disease
      0.61
      Agitation
      0.60
      Psychotic disorder
      0.59
      Bipolar I disorder
      0.58
      Hyperprolactinemia
      0.53
      Tourette syndrome
      0.53

      Genes and Related Targets

      Complexes and families that share a gene with this target
      Genes
      DRD4

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL219, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P21917, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.